Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

303 Press Releases
DateTitleCompany
17 Jan 12 Teva to Report Fourth Quarter and Full Year 2011 Financial Results on February 15, 2012 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Jan 12 Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Jan 12 Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Jan 12 Teva Announces Management Succession Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Dec 11 Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
21 Dec 11 Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
21 Dec 11 Teva Announces $3 billion Share Repurchase Program Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Dec 11 Teva to Host 2012 Business Outlook Conference Call Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Dec 11 Teva to Present at the NASDAQ OMX 27th Investor Program Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Dec 11 CORRECTING and REPLACING Teva Announces Tentative Approval of Generic Lipitor® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Dec 11 Teva Announces Tentative Approval of Generic Lipitor® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Dec 11 Teva Announces Agreement with Ranbaxy Regarding Generic Lipitor® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Nov 11 Teva to Present at the 23rd Annual Piper Jaffray Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Nov 11 Teva to Present at the Credit Suisse 2011 Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Nov 11 Teva Announces Pricing of $5,000,000,000 of Senior Notes Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Nov 11 The Procter & Gamble Company and Teva Pharmaceutical Industries Announce Formation of New Consumer Health Care Partnership Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Nov 11 Teva Provides Updated 2011 Financial Outlook Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Nov 11 Teva Reports Third Quarter 2011 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Oct 11 Teva Presents New Data on QNASL™ at the 2011 American College of Allergy, Asthma and Immunology Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Oct 11 Teva and Dr. Reddy’s Announce Launch of Generic Zyprexa® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Oct 11 Treatment with COPAXONE® in Multiple Sclerosis Demonstrated Remyelination and Neuroprotective Effects in a Preclinical Setting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Oct 11 Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Oct 11 New Data on Teva’s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Oct 11 Teva Completes Acquisition of Cephalon Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Oct 11 Teva and Cephalon Receive European Commission Approval For Acquisition Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Oct 11 Significant Reduced Loss of Brain Volume in Multiple Sclerosis Patients Treated with COPAXONE® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Oct 11 U.S. Federal Trade Commission Clears Teva's Acquisition of Cephalon Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 11 Teva to Report Third Quarter 2011 Financial Results on November 2, 2011 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Oct 11 Teva Respiratory Provides Resources for Patients Impacted by PRIMATENE® MIST Phase-Out Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Sep 11 Teva Solidifies Japanese Operations with Complete Buyout of Partner's Interest in Teva's Japanese Joint Venture Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.